ER is a nuclear hormone receptor, present in benign epithelial cells and in a majority of invasive breast cancers (4), and the binding of the estrogen steroid to the ER stimulates epithelial proliferation (5). This evidence concerns the gene ESR1 and invasive breast carcinoma.